alternative intravesical therapy and patient preferences in nmibc
Published 2 weeks ago • 84 plays • Length 6:07Download video MP4
Download video MP3
Similar videos
-
4:12
systemic versus intravesical therapy for nmibc
-
7:14
alternative treatments for refractory to bcg nmibc
-
40:36
treatment paradigms for intermediate and high-risk non-muscle invasive bladder cancer
-
1:43:06
intravesical therapy for bladder cancer past, present & future
-
9:12
immunotherapy for nmibc: emerging and expanding indications
-
4:28
very high risk non-muscle-invasive bladder cancer (nmibc) in the current landscape of nmibc
-
10:35
management of bcg unresponsive cystectomy ineligible bladder cancer patients pembrolizumab
-
19:31
adaptive immune resistance to intravesical bcg in nmibc: bcg-unresponsive clinical trials
-
3:31
what is intravesical therapy? | bladder cancer advocacy network
-
26:18
controversies in non-muscle invasive bladder cancer (nmibc): guidelines and beyond 2023
-
10:46
new treatment of non-muscle-invasive bladder cancer
-
3:53
non-muscle-invasive bladder cancer management post-bcg therapy | backtable urology clips
-
51:36
treatment of high risk nmibc in era of bcg shortage - empire urology lecture series
-
29:46
introduction to adstiladrin | gene therapy for bcg unresponsive nmibc
-
1:08
future treatment approaches for patients with bladder cancer
-
19:16
checkpoint inhibitors for nmibc
-
2:39
does every patient with localized muscle-invasive bladder cancer need a cystectomy?
-
26:20
management of non-muscle invasive bladder cancer